4 insiders reported 6 Form 4 transactions for Vivos Therapeutics, Inc. (VVOS) over the past 18 months (most recent 2026-09-18). Recent activity: Huntsman Ronald Kirk (Chief Executive Officer) Buy 85,910 shares, Amman Bradford K. (Principal Accounting Officer) Buy 250,000 shares, Skaff Michael C (10% Owner) Buy 1.0M shares, V-Co Investors 3 LLC (10% Owner) Buy 1.0M shares, Skaff Michael C (10% Owner) Buy 308,848 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-18 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 85,910 | $50,000 |
| 2026-08-26 | Amman Bradford K. | Principal Accounting Officer | Buy | 250,000 | $102,500 |
| 2026-04-02 | Skaff Michael C | 10% Owner | Buy | 1.0M | $1.4M |
| 2026-04-02 | V-Co Investors 3 LLC | 10% Owner | Buy | 1.0M | $1.4M |
| 2026-04-02 | Skaff Michael C | 10% Owner | Buy | 308,848 | $413,856 |
| 2026-04-02 | V-Co Investors 3 LLC | 10% Owner | Buy | 308,848 | $413,856 |
来源：SEC Form 4 申报文件 · 截至 2026-09-18